Israeli clinic begins study for fourth corona vaccination
The flag of Israel. pixabay.com
TEL AVIV (dpa-AFX) – According to its own information, an Israeli hospital will begin a study for the fourth vaccination against the corona virus on Monday. Around 150 medical workers at the clinic, who had received their third vaccination by August 20, would receive another dose, the Shiba Hospital near Tel Aviv announced on Sunday evening. All of them would have had low levels of antibodies in a serological test – below 700. According to the hospital, this is the first study of its kind in the world.
Gili Regev-Jochai, director of the Infectious Diseases Department, said, “In this study we will review what the impact of the fourth vaccination is on antibody counts, disease prevention, and we will monitor safety.”
In view of the spread of the omicron variant of the coronavirus, Israel had already announced last week that people over 60 should receive a fourth dose of vaccine. A government panel of experts also recommended that health care workers should also be vaccinated for the fourth time.
Israel has already passed the fourth corona wave. Recently, however, the number of infections has risen again. Only around 60 percent of the 9.4 million Israelis are still considered fully vaccinated. These are twice vaccinated up to 6 months after the second vaccination and people with booster vaccination. 31 percent of the population are not vaccinated at all, with nine percent the vaccination has already expired./jak/DP/nas
Subscribe to more news about HHLA shares free of charge
ARIVA.DE publishes analyzes, columns and news from various sources in this section. ARIVA.DE AG is not responsible for content that has been recognized by third parties in the “News” area of this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” mark below the article heading and / or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.
Other users were also interested in this article: